Bispecific antigen binding molecule for a costimulatory TNF receptor

The invention relates to novel bispecific antigen binding molecules comprising (a) at least one moiety capable of specific binding to OX40, and (b) at least one moiety capable of specific binding to tenascin C (TnC), and to methods of producing these molecules and to methods of using the same.

Saved in:
Bibliographic Details
Main Authors Amann, Maria, Pincha, Mudita, Klein, Christian, Umaña, Pablo, Grau-Richards, Sandra
Format Patent
LanguageEnglish
Published 27.09.2022
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to novel bispecific antigen binding molecules comprising (a) at least one moiety capable of specific binding to OX40, and (b) at least one moiety capable of specific binding to tenascin C (TnC), and to methods of producing these molecules and to methods of using the same.
Bibliography:Application Number: US201916584931